Patent · US Active

Substituted isoindolines as aspartyl protease inhibitors

US8722708B2 · kind B2 · utility

1Cited by
4References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 12, 2006
Grant dateMay 13, 2014
Priority date—
Expiry dateSep 28, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are compounds of the formula Ior a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.